Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. Audited financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vista Pharmaceuticals Ltd has informed BSE that a meeting of its Board of Directors is scheduled for 29th May 2026 at the company's registered office. The meeting will consider and approve the audited financial results for the quarter and year ended 31st March 2026, along with the audit report for the same period. This is a routine intimation filed under SEBI Listing Regulations. No actual financial results or numbers are disclosed in this filing. The company will announce the results after the board meeting.
This is a standard pre-result announcement intimation with no immediate impact on shareholders. Actual financial performance and any significant disclosures will be known only after the board meeting approves and releases the results.